{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:02:13Z","timestamp":1740157333260,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12928-019-00576-y","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T08:20:18Z","timestamp":1550132418000},"page":"305-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Full-metal jacket technique using second-generation drug-eluting stent: clinical and angiographic follow-up in 2 years"],"prefix":"10.1007","volume":"34","author":[{"given":"Goro","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6673-0167","authenticated-orcid":false,"given":"Nehiro","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ashikaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"issue":"3","key":"576_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0735-1097(99)00303-4","volume":"34","author":"Y Kobayashi","year":"1999","unstructured":"Kobayashi Y, Gregorio J, Kobayashi N, Akiyama T. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol. 1999;34(3):651\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"576_CR2","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1161\/CIRCULATIONAHA.105.552190","volume":"112","author":"KD Dawkins","year":"2005","unstructured":"Dawkins KD, Grube E, Guagliumi G, Banning AP, TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005;112(21):3306\u201313.","journal-title":"Circulation."},{"issue":"5","key":"576_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ahj.2005.01.050","volume":"150","author":"J Aoki","year":"2005","unstructured":"Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP. \u201cFull metal jacket\u201d (stented length\u2009>\u2009or\u2009=\u200964\u00a0mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J. 2005;150(5):994.","journal-title":"Am Heart J"},{"issue":"7","key":"576_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.amjcard.2006.05.011","volume":"98","author":"CW Lee","year":"2006","unstructured":"Lee CW, Park KH, Kim YH, Hong MK. Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions. Am J Cardiol. 2006;98(7):918\u201322.","journal-title":"Am J Cardiol"},{"issue":"2","key":"576_CR5","first-page":"46","volume":"21","author":"M Andron","year":"2009","unstructured":"Andron M, Ramsdale DR, Rao A, Ramsdale KA. Clinical outcomes after percutaneous coronary intervention involving very long segments of drug-eluting stent implantation: single-center experience. J Invasive Cardiol. 2009;21(2):46\u201350.","journal-title":"J Invasive Cardiol."},{"key":"576_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jacc.2004.11.065","volume":"45","author":"R Moreno","year":"2005","unstructured":"Moreno R, Fernandez C, Hernandez R, Alfonso. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45:954\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"576_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.amjcard.2005.01.039","volume":"95","author":"L Mauri","year":"2005","unstructured":"Mauri L, O\u2019Malley AJ, Popma JJ, Moses JW. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005;95:1140\u20135.","journal-title":"Am J Cardiol"},{"key":"576_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcin.2010.09.027","volume":"4","author":"AM Latib","year":"2011","unstructured":"Latib AM, Ielasi A, Tarsia G, Mussardo A. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4:155\u201364.","journal-title":"JACC Cardiovasc Interv."},{"key":"576_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4244\/EIJV5I6A116","volume":"5","author":"F Tagliareni","year":"2010","unstructured":"Tagliareni F, La Manna A, Saia F, Marzocchi A. Long-term clinical follow-up of drug-eluting stent restenosis treatment: retrospective analysis from two high volume catheterisation laboratories. EuroIntervention. 2010;5:703\u20138.","journal-title":"EuroIntervention"},{"issue":"7","key":"576_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/ccd.25455","volume":"84","author":"S Basavarajaiah","year":"2014","unstructured":"Basavarajaiah S, Naganuma T, Latib A, Hasegawa T. Extended follow-up following \u201cfull-metal jacket\u201d percutaneous coronary interventions with drug-eluting stents. Catheter Cardiovasc Interv. 2014;84(7):1042\u201350.","journal-title":"Catheter Cardiovasc Interv."},{"issue":"4","key":"576_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.amjcard.2008.10.010","volume":"103","author":"J Liu","year":"2009","unstructured":"Liu J, Maehara A, Mintz GS, Weissman NJ. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J Cardiol. 2009;103(4):501\u20136.","journal-title":"Am J Cardiol"},{"issue":"11","key":"576_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"4","author":"BE Claessen","year":"2011","unstructured":"Claessen BE, Smits PC, Kereiakes DJ, Parise H. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent. JACC Cardiovasc Interv. 2011;4(11):1209\u201315.","journal-title":"JACC Cardiovasc Interv."},{"issue":"6","key":"576_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jjcc.2016.09.014","volume":"69","author":"K Yamamoto","year":"2017","unstructured":"Yamamoto K, Sakakura K, Adachi Y, Taniguchi Y. Comparison of mid-term clinical outcomes between \u201ccomplete full-metal jacket strategy\u201d versus \u201cincomplete full-metal jacket strategy\u201d for diffuse right coronary artery stenosis with drug-eluting stents. J Cardiol. 2017;69(6):823\u20139.","journal-title":"J Cardiol"},{"issue":"5","key":"576_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jjcc.2017.10.011","volume":"71","author":"H Yano","year":"2018","unstructured":"Yano H, Horinaka S, Ishimitsu T. Impact of everolimus-eluting stent length on long-term clinical outcomes of percutaneous coronary intervention. J Cardiol. 2018;71(5):444\u201351.","journal-title":"J Cardiol"},{"issue":"14","key":"576_CR15","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jcin.2017.04.026","volume":"10","author":"PH Lee","year":"2017","unstructured":"Lee PH, Lee SW, Yun SC, Bae J. Full metal jacket with drug-eluting stents for coronary chronic total occlusion. JACC Cardiovasc Interv. 2017;10(14):1405\u201312.","journal-title":"JACC Cardiovasc Interv"},{"key":"576_CR16","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","volume":"115","author":"TF L\u00fcscher","year":"2007","unstructured":"L\u00fcscher TF, Steffel J, Eberli FR, Joner M. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051.","journal-title":"Circulation"},{"key":"576_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","volume":"125","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber L, Magro M, Stefanini GG, Kalesan B. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation. 2012;125:1110\u201321.","journal-title":"Circulation"},{"key":"576_CR18","first-page":"12636","volume":"12","author":"A Alazzoni","year":"2012","unstructured":"Alazzoni A, Al-Saleh A, Jolly SS. Everolimus-eluting versus paclitaxel-eluting stents in percutaneous coronary intervention: meta-analysis of randomized trials. Thrombosis. 2012;12:12636\u20139.","journal-title":"Thrombosis."},{"key":"576_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCINTERVENTIONS.111.963256","volume":"4","author":"A Waha de","year":"2011","unstructured":"de Waha A, Dibra A, Byrne RA. Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials. Circ Cardiovasc Interv. 2011;4:371\u20137.","journal-title":"Circ Cardiovasc Interv."},{"key":"576_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","volume":"125","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Thayssen P, Hansen HS, Christiansen EH. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV). Circulation. 2012;125:1246.","journal-title":"Circulation"},{"key":"576_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2012.05.038","volume":"60","author":"R Valenti","year":"2012","unstructured":"Valenti R, Migliorini A, Parodi G. Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease. J Am Coll Cardiol. 2012;60:1217\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"576_CR22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4244\/EIJV6I8A162","volume":"6","author":"S Garg","year":"2011","unstructured":"Garg S, Wykrzykowska J, Serruys PW. The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. EuroIntervention. 2011;6:928\u201335.","journal-title":"EuroIntervention."},{"key":"576_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.amjcard.2016.11.038","volume":"119","author":"Ryuta Sugihara","year":"2017","unstructured":"Sugihara Ryuta. Outcomes of first- versus second-generation drug-eluting. Am J Cardiol. 2017;119:852\u20135.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12928-019-00576-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-019-00576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-019-00576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T19:37:52Z","timestamp":1581622672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12928-019-00576-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1007\/s12928-019-00576-y","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"type":"print","value":"1868-4300"},{"type":"electronic","value":"1868-4297"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. Informed consent was obtained from all patients who were included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statements and ethical standards"}}]}}